Dr Satyendra Katewa
Director – Hemato-Oncology & Bone Marrow Transplant, Paediatric Oncology
Max Super Speciality Hospital, Saket
CRISPR, DNB, MBBS, Fellowship
18 years of overall experience
New Delhi, India
About the Doctor
Education & Training
- CRISPR – Harvard University, USA (2020)
- Fellowship – (Paediatric Haemato-Oncology & BMT), University of Toronto, Canada (2011)
- Fellowship – (Paediatric Haemato-Oncology & BMT), Sir Ganga Ram Hospital (SGRH), New Delhi (2009)
- DNB (Paediatrics) – Sir Ganga Ram Hospital, New Delhi (2007)
- MBBS – Sardar Patel Medical College, Bikaner (1998)
Memberships
- Rajasthan Medical Council
- Delhi Medical Council
- Indian Academy of Pediatrics (IAP)
- Paediatric Hematology Oncology (PHO) Chapter of IAP
- International Society of Paediatric Oncology (SIOP)
- American Society of Paediatric Hemato-Oncology (ASPHO)
- American Society of Bone Marrow Transplant (ASBMT)
- European Society of Immunodeficiency Diseases (ESID)
Speciality Interest
- Leukaemia (ALL & AML)
- Lymphoma (Hodgkin & Non - Hodgkin)
- Myelodysplasia & Solid Tumors
- Haematology (Thalassemia, Haemophilia, ITP, Aplastic Anaemia, Immunodeficiency Disorders, Nutritional Anaemia & Haemolytic Anaemia)
- BMT (Autologous & Allogeneic)
- Mismatched Allogeneic BMT (Haploidentical BMT)
- T-Cell (Depleted Haploidentical BMT)
Research Papers & Publications
- Publication on "Selection and Pre-Transplant Evaluation of Donor and Recipient in Haematopoietic Cell Transplantation", Textbook Contemporary Bone Marrow Transplantation
- Publication on "Outcome of TCR αβ and CD19 Depletion Vs. Post-Transplant Cyclophosphamide Haploidentical Hematopoietic Stem Cell Transplant in patients with Thalassemia Major", A Comparative Analysis, European BMT Meeting 2025
- Publication on “MRD negative CR after Azacitidine and Venetoclax in a young patient with AML, unfit for intensive induction followed by ASCT", Volume 16, Leukemia Research Reports
- Publication on "Successful Haploidentical Stem Cell Transplant With Posttransplant Cyclophosphamide for Haemophagocytic Lymphohistiocytosis", Journal of Paediatric Haematology/Oncology
- Publication on "Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse", Pediatric Blood & Cancer
Experience
- Dr Satyendra Katewa is currently working at Max Healthcare.
- Director – Haemato-Oncology, Paediatric Oncology, BMT & Cellular Therapy, Shalby Sanar International Hospital, Gurugram (2024 - 2025)
- HOD – Paediatric Haemato-Oncology, BMT, & Cellular Therapy, Manipal Hospital Dwarka, Delhi (2023 - 2024)
- HOD – Paediatric Haemato-Oncology & Bone Marrow Transplant, Manipal Hospital, Jaipur, Rajasthan (2015 - 2023)
- Consultant – Paediatric Haemato-Oncology & Bone Marrow Transplant, Fortis Memorial Research Institute, Gurgaon (2013 - 2015)
- Clinical Associate – Bone Marrow Transplant Unit, Division of Paediatric Haemato- Oncology, Hospital for Sick Children “Sickkids”, Toronto, Canada (2012 - 2013)
- Clinical Associate – Paediatric Haemato-Oncologist & BMT, Dr B.L. Kapoor Memorial Hospital, New Delhi (2009 - 2011)
- Senior Registrar – Paediatric Haematology Oncology & Bone Marrow Transplant, Sir Ganga Ram Hospital, New Delhi (2006 - 2008)
- Resident – Paediatrics, Sardar Patel Medical College, Bikaner (2001 - 2003)
Hospitals
Max Super Speciality Hospital, Saket
New Delhi, India
Procedures
No detailed description available for this procedure.
FAQs
No FAQs available.
Reviews (0)
No reviews yet. Be the first to leave a review!